Project Grant R21AA033025
- The National Institute on Alcohol Abuse and Alcoholism awarded Northwestern University $100,228 on December 18, 2026, under the Alcohol Research Programs (CFDA 93.273) to investigate projection-specific endocannabinoid signaling mechanisms in ethanol-related behaviors. The research examines how ethanol affects endocannabinoid-cannabinoid receptor type 1 signaling at dorsolateral striatum terminals in the external segment of the globus pallidus, and how altered signaling at these terminals...
- Federal Grant Award Summary Northwestern University received a $2.1 million Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), effective September 23, 2025, through August 31, 2029. The project delivers fundamental neuroscience research investigating the neuropeptidergic regulation of valence processing and its contribution to sex differences in alcohol use disorder (AUD) development. The research focuses...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Washington $1,721,942 on July 20, 2026, under the Alcohol Research Programs (CFDA 93.273) to establish the Alcohol Research Consortium in HIV Center for Research at the Intersection of Equity, Alcohol, Community and HIV (ARCH REACH). ARCH REACH will develop, tailor, and implement evidence-based interventions for alcohol reduction targeting people with HIV experiencing unhealthy alcohol use, with emphasis on...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Houston System $706,832 on August 10, 2026, under the Alcohol Research Programs grant program (CFDA 93.273) to develop and evaluate a personalized digital intervention addressing hazardous alcohol use and negative affect among people with HIV. The intervention, called I-PFI (Integrated Personalized Feedback Intervention), is a single-session, computer-delivered program lasting 20–30 minutes that provides...
- The National Institute on Alcohol Abuse and Alcoholism awarded $4,718,683 to the Regents of the University of California, San Francisco on September 25, 2025, under the Alcohol Research Programs (CFDA 93.273) to establish the Center for Alcohol/HIV Innovations and Biomarker Research (CALIBER), a comprehensive research, training, and dissemination program addressing the intersection of unhealthy alcohol use and HIV transmission and comorbidity. CALIBER will develop and pilot test a motivational...
- The National Institute on Alcohol Abuse and Alcoholism awarded Loyola University of Chicago Health Sciences Campus $115,500 on August 17, 2026, under the Alcohol Research Programs (CFDA 93.273) to identify leading causes and pathways of death in alcoholic acute respiratory distress syndrome (ARDS) patients through computational analysis of clinical trial datasets. The recipient will conduct a retrospective cohort study validating findings across five NIH-funded, multicenter, randomized,...
- The National Institute on Alcohol Abuse and Alcoholism awarded Loyola University of Chicago Health Sciences Campus $470,066 on May 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct basic research on the molecular mechanisms by which ABL kinase 2 (ABL2) contributes to alcohol-associated liver disease pathogenesis. The research will investigate three specific areas: the molecular mechanisms by which ABL2 promotes alcohol-induced steatosis; the role of ABL kinases in...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Illinois $110,228 on November 10, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct time-resolved, single-nucleus multiomics research on HMGB1-mediated mechanisms of alcohol-associated liver disease progression and recovery. The project will deconvolute bulk RNA-sequencing datasets from human alcohol-associated liver disease samples using human single-cell RNA-sequencing references to quantify...
- The National Institute on Alcohol Abuse and Alcoholism awarded Emory University $497,748 under the Alcohol Research Programs (CFDA 93.273) on September 20, 2025, to develop and test an interactive text messaging intervention based on Construal Level Theory to reduce heavy drinking and HIV risk among young adult men. The award supports a K99/R00 career development grant structure in which the applicant will develop and refine theory-based text messaging content during the K99 phase, then test the...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Missouri System $1,413,058 on September 10, 2025, under the Alcohol Research Programs authority (CFDA 93.273) to conduct a longitudinal ecological momentary assessment study of alcohol consumption patterns and contexts across the transition to legal drinking age. The study employs a burst design to track 20-year-olds sampled from Missouri driver's license records (birth years 2005–2008, rural and small metro...
The National Institute on Alcohol Abuse and Alcoholism awarded Northwestern University $190,000 under the Alcohol Research Programs (CFDA 93.273) on September 1, 2026, to conduct multilevel research on alcohol use and HIV risk among young men in Chicago. The award funds an exploratory R21 project that will collect data from 150 young men ages 14–29 in Chicago, supplemented by 20 qualitative interviews. Aim 1 will characterize patterns of alcohol-related HIV vulnerability by integrating individual-, network-, and venue-level measures of alcohol and HIV risk into multivariable models, stratified by three developmental stages (underage 14–20, emerging adult 21–24, and adult 25–29) and contextualized with semi-structured qualitative interviews. Aim 2 will synthesize findings into a cross-level patterning framework and develop a prototype decision-support toolkit. The research addresses the gap between individual-level behavioral studies and empirical work on how alcohol-related HIV vulnerability emerges across relational and environmental contexts—peer networks, drinking partners, and specific venues—where young men drink. Northwestern University's Sponsored Research Division is the recipient. The period of performance runs through August 31, 2028, with work performed in Chicago, Illinois.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $190.0k | 8/27/26 |